Precision Medicine Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2022-2030

The global Precision Medicine market size is expected to be worth around US$ 95.5 billion by 2030, according to a new report by Vision Research Reports.

The global Precision Medicine market size was valued at US$ 50.0 billion in 2020 and is anticipated to grow at a CAGR of 11.9% during forecast period 2022 to 2030.

Growth Factors

Trends such as introduction of cost-effective genomic and molecular biology testing methods, increasing prevalence of cancer and rare diseases, and rising use of big data in precision medicine are some of the key factors boosting market growth.

The Human Genome Project introduced some marvelous cutting-edge techniques such as whole genome sequencing and targeted sequencing. These technologies are being used by researchers for the study of genomes and creation of personalized therapies for treatment of various illnesses. Today, the prevalence of diseases in areas such as oncology, immunology, and neurology has rapidly increased across the globe.

Researchers, healthcare professionals, and big pharma and biotech companies are working together to recognize new focused treatments options for the wellbeing of patients. Currently, there are many therapies and drugs under clinical trials for treatment of different types of cancers. Moreover, researchers have also shown an inclination toward development of precision medicines and diagnostics in non-oncologic disease areas.

Apart from therapeutics, the diagnostics field has also witnessed rapid growth in the past few years. The use of next generation sequencing (NGS), biomarkers, companion diagnostics, and esoteric tests can possibly change and affect prescription patterns of pharmaceutical medicines. Personalized medicines have very high chances of becoming a massive success in the next 20 years and have the capacity to treat and cure a few obstinate illnesses, which was not possible before.

Report Highlights

The overall market for precision medicines can be segmented into two major categories: therapeutics and diagnostics. Therapeutics segment can be further broken down into pharmaceuticals and medical devices. Whereas the diagnostics segments includes genetic tests, direct to consumer tests, esoteric tests, and others.

Under pharmaceuticals, oncology held the largest revenue share in 2020. One of the reasons behind this is growing prevalence of cancer and increasing number of drug candidates for the same under clinical trials. Additionally, the NIH is expected to invest approximately USD 70 billion in precision oncology, which will spur market growth. The respiratory and genetic diseases segments are also expected to witness significant growth in future.

Under the diagnostics segment, genetic tests are growing at the fastest pace. Precision diagnostics and therapeutics are expected to escalate the need for development of novel tools and techniques such as biomarkers, companion diagnostics, which can be used to efficiently treat patients.

Factors such as rising incidence of rare diseases, neurological diseases and cancers, increasing demand for precision drug therapies, growing pressure to reduce healthcare expenditure, and rising geriatric population are anticipated to boost market growth. Surge in strategic collaborations, resulting in higher number of clinical trials activities, and increasing government support and initiatives for development of better and efficient treatment options are expected to drive the market in the coming years.

Based on end use, the precision medicine diagnostics market is segmented into home care, hospitals, and clinical laboratories. Currently, clinical laboratories and hospitals hold the major share in precision diagnostics and medicines. However, the home care segment is expected to witness the highest growth during the forecast period.

Rising levels of acceptance and positive results obtained through precision therapies in treatment of various diseases among patients has benefitted the market. The market is further anticipated to be driven by the growth of personal healthcare equipment and devices, along with integration of smart technologies with various healthcare systems.

On the down side, high cost associated with precision diagnostic tests and medicine is a major drawback. In addition, the potential risk of device or software failure and security concerns over the privacy of patient data serve as key constraints to market growth. Stringent government regulations and standards are being devised and implemented in order to keep a check on these issues.

North America and Europe account for the largest share in the global market due to presence of a large number of leading pharmaceutical and biotech companies, along with well-established healthcare infrastructure. Furthermore, support from government entities, coupled with higher R & D investment, is driving these regional markets. For instance, in 2015, the then U.S. government announced the launch of the Precision Medicine Initiative to improve research and development in this field.

Key Players

Abbott Laboratories; Biogen Inc.; Foundation Medicine Inc.; Illumina, Inc.; Precision Biologics; IBM Watson; Siemens Healthineers; Janssen Pharmaceuticals; and GE Healthcare.

Market Segmentation

  • Application Outlook

    • Diagnostics

      • Genetic Tests

      • Direct to Consumer Tests

      • Esoteric Tests

      • Others

    • Therapeutics

      • Pharmaceuticals

        • Oncology

        • Respiratory Diseases

        • Skin Diseases

        • CNS Disorders

        • Immunology

        • Genetic Diseases

        • Others

    • Medical Devices

    • Others

  • End Use Outlook 

    • Home care

    • Hospitals

    • Clinical Laboratories

    • Others

  • Regional Outlook 

    • North America

      • U.S.

      • Canada

    • Europe

      • Germany

      • U.K.

    • Asia Pacific

      • China

      • Japan

    • Latin America

      • Brazil

    • Middle East & Africa

      • South Africa

The Precision Medicine market research report covers definition, classification, product classification, product application, development trend, product technology, competitive landscape, industrial chain structure, industry overview, national policy and planning analysis of the industry, the latest dynamic analysis, etc., and also includes major. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level.

The report provides size (in terms of volume and value) of Precision Medicine market for the base year 2020 and the forecast between 2021 and 2030. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.

This report focuses on the global Precision Medicine market status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Precision Medicine market development in United States, Europe and China.

It is pertinent to consider that in a volatile global economy, we haven’t just conducted Precision Medicine market forecasts in terms of CAGR, but also studied the market based on key parameters, including Year-on-Year (Y-o-Y) growth, to comprehend the certainty of the market and to find and present the lucrative opportunities in market.

In terms of production side, this report researches the Precision Medicine capacity, production, value, ex-factory price, growth rate, market share for major manufacturers, regions (or countries) and type.

In terms of consumption side, this report focuses on the consumption of Precision Medicine by regions (countries) and application.

Buyers of the report will have access to verified market figures, including global market size in terms of revenue and volume. As part of production analysis, the authors of the report have provided reliable estimations and calculations for global revenue and volume by Type segment of the global Precision Medicine market. These figures have been provided in terms of both revenue and volume for the period 2017 to 2030. Additionally, the report provides accurate figures for production by region in terms of revenue as well as volume for the same period. The report also includes production capacity statistics for the same period.

With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major Precision Medicine market companies.

Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of Precision Medicine market upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of market and consumption, major regions and Consumption, major Chinese producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.

The research in this report also includes product parameters, production process, cost structure, and data information classified by region, technology and application. Finally, the paper model new project SWOT analysis and investment feasibility study of the case model.

Overall, this is an in-depth research report specifically for the Precision Medicine industry. The research center uses an objective and fair way to conduct an in-depth analysis of the development trend of the industry, providing support and evidence for customer competition analysis, development planning, and investment decision-making. In the course of operation, the project has received support and assistance from technicians and marketing personnel in various links of the industry chain.

The Precision Medicine market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to Precision Medicine market.

Prominent players in the market are predicted to face tough competition from the new entrants. However, some of the key players are targeting to acquire the startup companies in order to maintain their dominance in the global market. For a detailed analysis of key companies, their strengths, weaknesses, threats, and opportunities are measured in the report by using industry-standard tools such as the SWOT analysis. Regional coverage of key companies is covered in the report to measure their dominance. Key manufacturers of Precision Medicine market are focusing on introducing new products to meet the needs of the patrons. The feasibility of new products is also measured by using industry-standard tools.

Key companies are increasing their investments in research and development activities for the discovery of new products. There has also been a rise in the government funding for the introduction of new Precision Medicine market. These factors have benefited the growth of the global market for Precision Medicine. Going forward, key companies are predicted to benefit from the new product launches and the adoption of technological advancements. Technical advancements have benefited many industries and the global industry is not an exception.

New product launches and the expansion of already existing business are predicted to benefit the key players in maintaining their dominance in the global market for Precision Medicine. The global market is segmented on the basis of region, application, en-users and product type. Based on region, the market is divided into North America, Europe, Asia-Pacific, Latin America and Middle East and Africa (MEA).

In this study, the years considered to estimate the market size of Precision Medicine are as follows:

  • Historic Year: 2017-2020
  • Base Year: 2021
  • Forecast Year 2021 to 2030

Reasons to Purchase this Report:

- Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
- Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
- Market value USD Million and volume Units Million data for each segment and sub-segment
- Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
- Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players

Research Methodology:

In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.

This research study involved the extensive usage of both primary and secondary data sources. The research process involved the study of various factors affecting the industry, including the government policy, market environment, competitive landscape, historical data, present trends in the market, technological innovation, upcoming technologies and the technical progress in related industry, and market risks, opportunities, market barriers and challenges. The following illustrative figure shows the market research methodology applied in this report.

Market Size Estimation

Top-down and bottom-up approaches are used to estimate and validate the global market size for company, regional division, product type and application (end users).

The market estimations in this report are based on the selling price (excluding any discounts provided by the manufacturer, distributor, wholesaler or traders). Market share analysis, assigned to each of the segments and regions are achieved through product utilization rate and average selling price.

Major manufacturers & their revenues, percentage splits, market shares, growth rates and breakdowns of the product markets are determined through secondary sources and verified through the primary sources.

All possible factors that influence the markets included in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data. The market size for top-level markets and sub-segments is normalized, and the effect of inflation, economic downturns, and regulatory & policy changes or others factors are accounted for in the market forecast. This data is combined and added with detailed inputs and analysis from Vision Research Reports and presented in this report.

Market Breakdown and Data Triangulation

After complete market engineering with calculations for market statistics; market size estimations; market forecasting; market breakdown; and data triangulation. Extensive primary research was conducted to gather information and verify and validate the critical numbers arrived at. In the complete market engineering process, both top-down and bottom-up approaches were extensively used, along with several data triangulation methods, to perform market estimation and market forecasting for the overall market segments and sub-segments listed in this report.

Secondary Sources

Secondary Sources occupies approximately 25% of data sources, such as press releases, annual reports, Non-Profit organizations, industry associations, governmental agencies and customs data, and so on. This research study includes secondary sources; directories; databases such as Bloomberg Business, Wind Info, Hoovers, Factiva (Dow Jones & Company), TRADING ECONOMICS, and avention; Investing News Network; statista; Federal Reserve Economic Data; annual reports; investor presentations; and SEC filings of companies.

Primary Sources

 In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include product manufacturers (and their competitors), opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the raw materials suppliers and producers, etc.

The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users (product buyers), and related key executives from various key companies and organizations operating in the global market.

The study objectives of this report are:

  • To analyze and study the global market capacity, production, value, consumption, status (2017-2020) and forecast (2021-2030);
  • Focuses on the key manufacturers, to study the capacity, production, value, market share and development plans in future.
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • To define, describe and forecast the market by type, application and region.
  • To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
  • To identify significant trends and factors driving or inhibiting the market growth.
  • To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
  • To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
  • To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
  • To strategically profile the key players and comprehensively analyze their growth strategies.

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Precision Medicine Market, By Application

7.1.  Precision Medicine Market, by Application, 2021-2028

7.1.1.    Diagnostics

7.1.1.1.        Market Revenue and Forecast (2016-2028)

7.1.2.    Therapeutics

7.1.2.1.        Market Revenue and Forecast (2016-2028)

7.1.3.    Medical Devices

7.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 8.  Global Precision Medicine Market, End Use

8.1.  Precision Medicine Market, End Use, 2021-2028

8.1.1.    Home care

8.1.1.1.        Market Revenue and Forecast (2016-2028)

8.1.2.    Hospitals

8.1.2.1.        Market Revenue and Forecast (2016-2028)

8.1.3.    Clinical Laboratories

8.1.3.1.        Market Revenue and Forecast (2016-2028)

Chapter 9.  Global Precision Medicine Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Application (2016-2028)

9.1.2.    Market Revenue and Forecast, End Use (2016-2028)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.1.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.1.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Application (2016-2028)

9.2.2.    Market Revenue and Forecast, End Use (2016-2028)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.5.2.        Market Revenue and Forecast, End Use (2016-2028)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.2.6.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Application (2016-2028)

9.3.2.    Market Revenue and Forecast, End Use (2016-2028)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.5.2.        Market Revenue and Forecast, End Use (2016-2028)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.3.6.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Application (2016-2028)

9.4.2.    Market Revenue and Forecast, End Use (2016-2028)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.4.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.5.2.        Market Revenue and Forecast, End Use (2016-2028)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Application (2016-2028)

9.4.6.2.        Market Revenue and Forecast, End Use (2016-2028)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Application (2016-2028)

9.5.2.    Market Revenue and Forecast, End Use (2016-2028)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Application (2016-2028)

9.5.3.2.        Market Revenue and Forecast, End Use (2016-2028)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Application (2016-2028)

9.5.4.2.        Market Revenue and Forecast, End Use (2016-2028)

Chapter 10.  Company Profiles

10.1.              Abbott Laboratories

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Biogen Inc.

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              Foundation Medicine Inc.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              Illumina, Inc.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              Precision Biologics

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              IBM Watson

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              Siemens Healthineers

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              Janssen Pharmaceuticals

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              GE Healthcare.

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Proceed To Buy

USD 4500
USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers